X0306 4 2022-02-01 0 0000884624 Orthofix Medical Inc. OFIX 0001536875 Serbousek Jon Carl 3451 PLANO PARKWAY LEWISVILLE TX 75056 1 1 0 0 CEO Common Stock 2022-02-01 4 A 0 81967 0.00 A 194779 D Performance Share Units 0.00 2022-02-01 4 A 0 81967 0.00 A Common Stock 81967 81967 D Represents time-based vesting restricted stock units that vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, February 1, 2022. Represents performance-based vesting restricted stock units ("PSUs") that will settle as common stock on a one-for-one basis. Under the terms of the grant, the PSUs may vest based upon achieved product revenues for the 2023 fiscal year (the "Product Revenue Vesting Percentage"), as modified by a total shareholder return ("TSR") modifier (the "TSR Modifier"). The amount in the table above represents the target number of PSUs granted. The performance period of the grant is 2/1/22-1/31/25. The Product Revenue Vesting Percentage can be achieved within a range of 50% to 200% of target, based upon the level of recognized revenues. If the Product Revenue Vesting Percentage is achieved at or above the threshold level, it shall be multiplied by the TSR Modifier (ranging from 0.75 to 1.25), which shall be determined based on the Company's relative TSR during the performance period as compared to a specified peer group. /s/ Kimberley A. Elting, Chief Legal and Development Officer, by power of attorney 2022-02-03